Literature DB >> 2718797

Enzymatic changes in the cerebrospinal fluid as indices of pathological change.

A Paşaoğlu1, H Paşaoğlu.   

Abstract

Enzymatic determinations in cerebrospinal fluid (CSF) of lactic dehydrogenase (LDH), creatine phosphokinase (CPK) and creatine kinase BB (CK-BB) were performed on 94 patients presenting with a range of disorders of the central nervous system. Enzyme results from 37 patients undergoing myelography were used as controls. The highest concentration of these enzymes appeared in patients with the most severe brain injury. In head-injured patients with a Glasgow Coma Score (GCS) of 3 to 7, only the CK-BB correlated with the degree of injury and with the ultimate outcome. Within the subgroup of spinal cord injuries none of the enzymes correlated with the severity of neurological injury. However, patients with acute spinal cord trauma who demonstrated CSF CK-BB values greater than 10 U/litre had never recovered. The present study confirms that CSF CK-BB seems to be a sensitive index of acute brain damage, but it reflects best the extent of CNS tissue disruption rather than the severity of neurological deficits.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2718797     DOI: 10.1007/BF01577743

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  44 in total

1.  Cerebrospinal fluid levels of myelin basic protein and creatin kinase BB as index of active demyelination.

Authors:  J Matias-Guiu; J M Martinez-Vazquez; A Ruibal; A Codina
Journal:  Acta Neurol Scand       Date:  1986-02       Impact factor: 3.209

2.  CKBB-isoenzymes as a sign of cerebral injury.

Authors:  L Rabow; G Hedman
Journal:  Acta Neurochir Suppl (Wien)       Date:  1979

3.  Spinal fluid and blood serum enzyme activity in brain injuries.

Authors:  B Klun
Journal:  J Neurosurg       Date:  1974-08       Impact factor: 5.115

4.  Lactate dehydrogenase and glutamic oxalacetic transaminase of the cerebrospinal fluid in neurological disease.

Authors:  G A Davies-Jones
Journal:  J Neurol Sci       Date:  1970-12       Impact factor: 3.181

5.  Serum and cerebrospinal fluid enzymes in cerebrovascular disease. Creatine phosphokinase, aldolase, and lactic dehydrogenase.

Authors:  A H Wolintz; L D Jacobs; N Christoff; M Solomon; N Chernik
Journal:  Arch Neurol       Date:  1969-01

6.  Creatine kinase isoenzymes in severe head injury.

Authors:  P Hans; J D Born; J P Chapelle; G Milbouw
Journal:  J Neurosurg       Date:  1983-05       Impact factor: 5.115

7.  Enzymatic changes in serum and cerebrospinal fluid in neurological injury.

Authors:  R A Bakay; A A Ward
Journal:  J Neurosurg       Date:  1983-01       Impact factor: 5.115

8.  Immunohistochemical localization of creatine kinase-BB isoenzyme to astrocytes in human brain.

Authors:  R J Thompson; P A Kynoch; J Sarjant
Journal:  Brain Res       Date:  1980-11-17       Impact factor: 3.252

9.  Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological disease.

Authors:  R D Bell; R N Rosenberg; R Ting; A Mukherjee; M J Stone; J T Willerson
Journal:  Ann Neurol       Date:  1978-01       Impact factor: 10.422

10.  The diagnostic value of measuring creatine kinase BB activity in cerebrospinal fluid following acute head injury.

Authors:  H K Nordby; P Urdal
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

View more
  3 in total

1.  Diagnostic value of creatine kinase activity in canine cerebrospinal fluid.

Authors:  Alexandra Ferreira
Journal:  Can Vet J       Date:  2016-10       Impact factor: 1.008

2.  Proteomic analysis of cerebrospinal fluid in canine cervical spondylomyelopathy.

Authors:  Paula Martin-Vaquero; Ronaldo C da Costa; Matthew J Allen; Sarah A Moore; Jeremy K Keirsey; Kari B Green
Journal:  Spine (Phila Pa 1976)       Date:  2015-05-01       Impact factor: 3.468

3.  Increases of neuron-specific enolase, S-100 protein, creatine kinase and creatine kinase BB isoenzyme in CSF following intraventricular catheter implantation.

Authors:  A Kruse; K G Cesarini; F W Bach; L Persson
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.